Filing Details

Accession Number:
0001209191-22-059677
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-05 16:21:21
Reporting Period:
2022-12-01
Accepted Time:
2022-12-05 16:21:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1822711 Pardes Biosciences Inc. PRDS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1208907 G Thomas Wiggans C/O Pardes Biosciences, Inc.
2173 Salk Ave., Suite 250, Pmb #052
Carlsbad CA 92008
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-01 25,000 $1.04 25,000 No 4 P Direct
Common Stock Acquisiton 2022-12-02 12,500 $1.07 37,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price in Column 4 is a weighted average purchase price. The prices actually paid ranged from $0.96025 to $1.05.
  2. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.
  3. The price in Column 4 is a weighted average purchase price. The prices actually paid ranged from $1.02 to $1.12.